Related Experiment Video
Updated: Jun 6, 2026

10:34
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
Published on: November 20, 2021
Robotic left pancreatectomy for pancreatic solid pseudopapillary tumor
Dimitrios Ntourakis1, Ettore Marzano, Vito De Blasi
1Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre--Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
Annals of Surgical Oncology
|November 20, 2010
Summary
Robotic distal pancreatectomy offers a minimally invasive approach for solid pseudopapillary pancreatic tumors. This technique provides oncological advantages, potentially reducing tumor cell dissemination during resection.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Gastrointestinal Surgery
Background:
- Solid pseudopapillary pancreatic tumors (SPPTs) are rare, low-grade malignant neoplasms predominantly affecting young females.
- Historically considered benign, SPPTs now require careful surgical management to prevent potential dissemination.
- Robotic surgery presents a promising minimally invasive option for SPPT resection.
Observation:
- A 28-year-old female with a 7-cm cystic lesion in the pancreatic tail, diagnosed as SPPT via MRI.
- The patient underwent a robotic distal splenopancreatectomy due to persistent high C-reactive protein levels.
- Serum tumor marker CA 19-9 was within normal limits preoperatively.
Findings:
- Robotic distal splenopancreatectomy was completed in 5 hours with minimal blood loss (250 mL).
- The postoperative period was uneventful, with discharge on day 8 and no evidence of pancreatic fistula.
- Histopathology confirmed a pT2pN0 solid pseudopapillary tumor, with normal 1-month follow-up.
Implications:
- Robotic surgery offers enhanced visualization, instrument dexterity, and a stable operative field for pancreatic tumor resection.
- This technique may minimize tumor cell dissemination and tissue trauma compared to traditional methods.
- Robotic distal pancreatectomy is a viable minimally invasive option for SPPTs, though further studies are needed to define its oncological indications.

